Genetic Influences in Psychopharmacology: Genetic Polymorphisms von Melissa Kalensky, FNP-BC, PMHNP-BC, CNE

Name: Genetic Influences in Psychopharmacology: Genetic Polymorphisms
Uploaded: 2025-11-11
Duration: 7 min 14 s
Description: Der Vortrag „Genetic Influences in Psychopharmacology: Genetic Polymorphisms“ von Melissa Kalensky, FNP-BC, PMHNP-BC, CNE ist Bestandteil des Kurses „Hormonal and Genetic Influences in Psychopharmacology“.

Über den Vortrag

Der Vortrag „Genetic Influences in Psychopharmacology: Genetic Polymorphisms“ von Melissa Kalensky, FNP-BC, PMHNP-BC, CNE ist Bestandteil des Kurses „Hormonal and Genetic Influences in Psychopharmacology“.

Quiz zum Vortrag

Genetic polymorphisms in cytochrome P450 enzymes primarily affect psychotropic medication metabolism by ...?

...altering how quickly the body breaks down and eliminates these drugs.
...changing the absorption rate of medications in the gastrointestinal tract.
...preventing medications from reaching the bloodstream after ingestion.
...increasing the production of new enzyme molecules in the liver.
...modifying how psychiatric symptoms respond to treatment.

On a genetic testing report for psychotropics, a medication labeled as ""yellow"" indicates ...?

...potential for a moderate gene-drug interaction requiring closer examination of the genetic profile.
...the medication is safe to use at standard dose without any genetic considerations.
...an absolute contraindication to using the medication regardless of genetic profile.
...the medication requires multiple enzyme pathways and needs no dose adjustments.
...a genetic mutation that completely prevents metabolism of the drug in the patient.

Exposure to polycyclic aromatic hydrocarbons from smoking results in enzyme induction at CYP1A2, which impacts drug metabolism by ...?

...speeding up drug breakdown and leading to sub-therapeutic concentrations and reduced control.
...slowing drug metabolism and increasing the risk of toxic accumulation in the bloodstream.
...preventing the liver from metabolizing medications through alternative enzyme pathways.
...completely blocking the elimination of medications processed through this enzyme system.
...enhancing the absorption of medications in the gastrointestinal tract significantly.

The primary advantage of using genetic testing in psychopharmacology is that it allows prescribers to ...?

...make medication decisions based on individual patient biology rather than population averages.
...completely eliminate the need for dose adjustments in all psychiatric patients.
...predict which psychiatric diagnosis a patient will develop based on their genetic profile.
...determine the exact dose without any clinical monitoring or patient assessment.
...identify all possible side effects a patient will experience before starting medication.

Diese Kurse könnten Sie interessieren

Psychopharmacology (APRN)

Melissa Kalensky, FNP-BC, PMHNP-BC, CNE

(1)

~~3,10 € mtl.~~ 1,99 € mtl.

Sie sparen 36 %

Hormonal and Genetic Influences in Psychopharmacology

Melissa Kalensky, FNP-BC, PMHNP-BC, CNE

(1)

~~1,00 € mtl.~~ 9,90 €

Sie sparen 1 %

Dozent des Vortrages Genetic Influences in Psychopharmacology: Genetic Polymorphisms

Melissa Kalensky, FNP-BC, PMHNP-BC, CNE

Dr. Melissa Kalensky, FNP-BC, PMHNP-BC, CNE is dual-certified as a Family Nurse Practitioner and a Psychiatric Mental Health Nurse Practitioner.

She specializes in primary care, community health, and integrated behavioral healthcare. Her expertise spans trauma-informed care and psychiatry across all age groups, from children to adults.

At Lecturio, she teaches psychopharmacology to advanced practice providers, helping to bridge the gap between psychiatric and primary care practice.

alle anzeigen Weniger anzeigen

Kundenrezensionen

(1)
5,0 von 5 Sternen

5 Sterne		5
4 Sterne		0
3 Sterne		0
2 Sterne		0
1 Stern		0

oder

Vortrag freischalten 1,00 €